Brett King, MD, PhD

Brett King, MD, PhD
Accepting new patients? Yes
Referrals required? From physicians only
Patient type treated: Child; Adult; Older Adult

Brett King, MD, PhD, a Yale Medicine dermatologist and associate professor of dermatology at Yale School of Medicine, specializes in skin diseases refractory to first-line therapies. 

Dr. King has pioneered the use of Janus Kinase (JAK) inhibitors in dermatology, and his work has revealed the broad utility of JAK inhibitors for the treatment of alopecia areata, vitiligo, granuloma annulare and sarcoidosis, lichen planus, and atopic dermatitis. 

Dr. King is an internationally recognized expert in alopecia areata, a chronic skin condition that causes patchy hair loss or even loss of all body hair. 

When people have this condition, the body’s immune system attacks the hair follicles. It can lead to the loss of hair on the head, eyebrows, eyelashes, beard and/or body. Dr. King understands the profound consequences this often has on peoples’ lives.  “Alopecia areata causes so much anxiety and despair for patients and their families—it can be devastating,” he says.

Dr. King is an investigator in numerous clinical trials. He has lectured nationally and internationally and has published extensively.

Clinical Trials

New treatments for many conditions are tested in clinical trials, which ultimately bring lifesaving new drugs and devices to the patients who need them most. By participating in a clinical trial, you may get access to the most advanced treatments for your condition, and help determine their benefits for future patients.